Neoadjuvant radiotherapy and capecitabine with or without panitumumab in patients with advanced, K-ras unmutated rectal cancer. A randomized multicenter phase II trial

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-006012-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the efficacy and safety of the neoadjuvant regimen of capecitabine and external beam radiotherapy in combination with panitumumab in patients with advanced K-ras unmutated rectal cancer.


Critère d'inclusion

  • Advanced K-ras unmutated rectal cancer

Liens